This is a recognised class effect of GLP-1 receptor agonists
As the first and only dual-activating GIP and GLP-1 obesity treatment, ZEPBOUND, Eli Lilly weight loss medication, addresses a key factor contributing to excess weight by curbing appetite and reducing food intake
Adding more physical activity , whether its resistance training or simply walking more, can also help
If the lump remains unchanged or becomes more noticeable, it may require closer attention to ensure it is following a normal pattern
Result Discard on or after Sunday, August 30, 2026 28 days remaining
Knowing how to handle these situations is essential for maintaining the momentum of your program